For patients with er or pr positive, stage ic-iii breast cancer, clinician documented or prescribed that the patient is receiving tamoxifen or aromatase inhibitor
Added on Sunday, July 01, 2007
Terminated on Friday, December 31, 2010: do not use.
Status changed on Saturday, January 01, 2011 to: No maintenance for this code
2013 HCPCS G8381
